Skip to main content

Table 3 Magnesium concentration at baseline and end of the study

From: A randomized clinical trial investigating the impact of magnesium supplementation on clinical and biochemical measures in COVID-19 patients

Variable

Magnesium group

Placebo group

  

Value

P1

Value

P1

P2

P3

Magnesium

Baseline

2.25 ± 0.28

0.15

2.28 ± 0.37

0.027

0.55

 

End of the study

2.34 ± 0.33

2.07 ± 0.32

0.004

 

Changes

0.092 ± 0.34

 

-0.21 ± 0.08

 

0.003

0.001

  1. P1, Paired sample t-test; P2, Independent sample t-test, P3, ANCOVA adjusted for weight, energy intake
Back to article page

Virology Journal

ISSN: 1743-422X